Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented MassMutual Ventures in the transaction. Cultivo announced it raised $14 million in Series A financing, to accelerate its mission...
Cultivo’s $14 Million Series A Financing Round
Prove Identity’s $40 Million Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented MassMutual Ventures in the transaction. Prove Identity announced $40 million funding round led by MassMutual Ventures and Capital One Ventures. The...
Osmoses’ $11 Million Series Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Osmoses in the transaction. Osmoses announced its $11 million Series Seed financing led by Energy Capital Ventures, and included...
Solu Therapeutics’ $31 Million Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Solu Therapeutics in the transaction. Solu Therapeutics announced the closing of an oversubscribed $31 million seed financing co-led...
LightForce Orthodontics’ $80 Million Series D Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented LightForce Orthodontics in the transaction. LightForce Orthodontics announced its $80 million Series D financing led by Ally Bridge Group....
AltC Acquisition Corp.’s Business Combination with Oklo
Weil, Gotshal & Manges LLP represented AltC Acquisition Corp., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Oklo Inc. in the transaction. An advanced...
Anthropic’s $450 Million Series C Financing Round
Gunderson Dettmer represented Spark Capital on the deal. Anthropic, the prominent generative AI startup co-founded by OpenAI veterans, has raised $450 million in Series C funding...
Toku’s $7 Million Seed Series Investment Round
CMS Carey & Allende and Wilmer Cutler Pickering Hale and Dorr advised Toku, while Carey & Co. and Gunderson Dettmer advised F-Prime on the transaction. Toku closed...
RIGImmune’s Acquisition of Subintro
Gunderson Dettmer represented RIGImmune on the deal. RIGImmune, a biopharmaceutical company developing a new class of RNA immunotherapeutics, announced its acquisition of Subintro, a biotechnology company specializing...
Photys Therapeutics’ $75 Million Series A Financing
Gunderson Dettmer advised Photys Therapeutics on the deal. Photys Therapeutics, a developer of phosphorylation-inducing chimeric small molecule (PHICS) medicines, announced its $75 million Series A financing...
Carbon Biosciences’ $38 Million Series A Financing
Gunderson Dettmer represented Carbon Biosciences on the deal. Carbon Biosciences, a developer of novel parvovirus-derived gene therapies, announced its emergence from stealth mode and the closing of...
Triple Whale’s $27.7 Million Series A Financing
Gunderson Dettmer represented Elephant on the deal. Elephant led the $27.7 million Series A financing of Triple Whale, an all-in-one operating system for Shopify. Triple Whale’s platform...